Enanta Pharmaceuticals, Inc. entered into an Open Market Sale Agreement with Jefferies LLC to sell up to $75,000,000 in common stock through an at-the-market offering. The company will pay Jefferies LLC a commission of up to 3.0% of the gross sales price per share. Enanta Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing small molecule drugs.
